EP0294390A1 - Peptide mit wirkung auf die blutdruckregelung - Google Patents
Peptide mit wirkung auf die blutdruckregelungInfo
- Publication number
- EP0294390A1 EP0294390A1 EP19870901916 EP87901916A EP0294390A1 EP 0294390 A1 EP0294390 A1 EP 0294390A1 EP 19870901916 EP19870901916 EP 19870901916 EP 87901916 A EP87901916 A EP 87901916A EP 0294390 A1 EP0294390 A1 EP 0294390A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- val
- leu
- tyr
- peptide
- glu
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/14—Angiotensins: Related peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/38—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against protease inhibitors of peptide structure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Vascular Medicine (AREA)
- Immunology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US83079586A | 1986-02-19 | 1986-02-19 | |
US830795 | 1986-02-19 | ||
US229887A | 1987-01-20 | 1987-01-20 | |
US2298 | 1987-01-20 |
Publications (1)
Publication Number | Publication Date |
---|---|
EP0294390A1 true EP0294390A1 (de) | 1988-12-14 |
Family
ID=26670201
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP19870901916 Withdrawn EP0294390A1 (de) | 1986-02-19 | 1987-02-19 | Peptide mit wirkung auf die blutdruckregelung |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP0294390A1 (de) |
AU (1) | AU595597B2 (de) |
WO (1) | WO1987005029A2 (de) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1989011657A1 (en) * | 1988-05-25 | 1989-11-30 | Cambridge Research Biochemicals Limited | Assay for oncogene expression |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5077195A (en) * | 1985-03-01 | 1991-12-31 | Board Of Reagents, The University Of Texas System | Polypeptides complementary to peptides or proteins having an amino acid sequence or nucleotide coding sequence at least partially known and methods of design therefor |
-
1987
- 1987-02-19 EP EP19870901916 patent/EP0294390A1/de not_active Withdrawn
- 1987-02-19 AU AU71258/87A patent/AU595597B2/en not_active Ceased
- 1987-02-19 WO PCT/US1987/000367 patent/WO1987005029A2/en not_active Application Discontinuation
Non-Patent Citations (1)
Title |
---|
See references of WO8705029A2 * |
Also Published As
Publication number | Publication date |
---|---|
WO1987005029A2 (en) | 1987-08-27 |
AU595597B2 (en) | 1990-04-05 |
AU7125887A (en) | 1987-09-09 |
WO1987005029A3 (en) | 1987-11-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4772684A (en) | Peptides affecting blood pressure regulation | |
US4493795A (en) | Synthetic peptide sequences useful in biological and pharmaceutical applications and methods of manufacture | |
US4686283A (en) | Analogs of transforming and epidermal growth factor fragments for therapy and diagnosis | |
JP2850259B2 (ja) | 心房の,ナトリウム排出亢進性ペプチドの環式アナログ | |
US5449662A (en) | Atrial natriuretic peptide clearance inhibitors which resist degradation | |
EP0313651B1 (de) | Synthetische peptiden zur diagnose und behandlung der grippe | |
US4833166A (en) | Growth hormone releasing hormone complementary peptides | |
US4859765A (en) | Synthetic peptide sequences useful in biological and pharmaceutical applications and methods of manufacture | |
US4864019A (en) | Antibodies to inhibin and conjugates produced therefrom | |
EP0246753A2 (de) | Antagonisten des Fibroblasten-Wachstumsfaktors | |
CA2000048A1 (en) | Peptides and antibodies that inhibit integrin-ligand bindin g | |
WO1994020534A1 (en) | Vasonatrin peptide and analogs thereof | |
US5106834A (en) | Linear free-sulfhydryl-containing oligopeptide derivatives as antihypertensive agents | |
US5230999A (en) | Monoclonal antibody to endothelin-3 or precursor thereof and use thereof | |
JP2735233B2 (ja) | 合成ペプチドおよびそれに対する抗体 | |
Bidart et al. | Antigenic determinants on human choriogonadotropin alpha-subunit. I. Characterization of topographic sites recognized by monoclonal antibodies. | |
US4543340A (en) | Radioimmunoassay of thymosin β4 | |
Troalen et al. | Antigenic determinants on human choriogonadotropin alpha-subunit. II. Immunochemical mapping by a monoclonal antipeptide antibody. | |
US4721704A (en) | Potent synthetic atrial peptide analogs | |
US5087562A (en) | Humoral hypercalcemic factor antagonists with modification at position 13 . . . | |
US6010864A (en) | Peptides representing epitopic sites on r-IFN-β,antibodies thereto, and uses thereof | |
AU595597B2 (en) | Peptides affecting blood pressure regulation | |
US5869603A (en) | Peptides representing eptiopic sites on r-IFN-β, antibodies thereto, and uses thereof | |
WO1987005029A1 (en) | Peptides affecting blood pressure regulation | |
US5087561A (en) | Humoral hypercalcemic factor antagonists modified at position 13 by biotin |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 19880802 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH DE FR GB IT LI LU NL SE |
|
17Q | First examination report despatched |
Effective date: 19910211 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 19910902 |
|
RIN1 | Information on inventor provided before grant (corrected) |
Inventor name: BRUNCK, TERENCE, K. Inventor name: COLBY, CLARENCE, B., JR. |